CytoMed Therapeutics Limited (GDTC) vs KALA BIO, Inc. (KALA)

CytoMed Therapeutics Limited and KALA BIO, Inc. are both Biotechnology companies. CytoMed Therapeutics Limited and KALA BIO, Inc. are of similar size ($10.8M and $10.7M). Across the 10 metrics below, CytoMed Therapeutics Limited leads on 5 and KALA BIO, Inc. on 5.

Valuation

Metric GDTC KALA Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.01 11.47
P/B 488.81 0.00 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 7.52 10.73
Earnings yield (29.17%) (6,658.33%) (28.84%)
Free cash flow yield (0.35%) (56,050.65%) (23.03%)

Profitability

Metric GDTC KALA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (345.32%) (57.72%)
Return on assets 0.00% (43.23%) (49.22%)
Return on invested capital 0.00% (722.69%) 0.00%

Growth

Metric GDTC KALA Biotechnology median
Revenue growth (TTM) — (50.54%) 5.64%
EPS growth (last fiscal year) (68.75%) 67.39% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GDTC KALA Biotechnology median
Debt to equity 0.07 0.00 0.00
Current ratio 5.17 6.88 4.73
Net debt to EBITDA 0.86 0.19 0.96

Dividend

Metric GDTC KALA Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric GDTC KALA Biotechnology median
Market cap 10.77m 10.73m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack